These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 15667130)

  • 21. A segmented principal component analysis-regression approach to quantitative structure-activity relationship modeling.
    Hemmateenejad B; Elyasi M
    Anal Chim Acta; 2009 Jul; 646(1-2):30-8. PubMed ID: 19523553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of QSAR models to predict and interpret the biological activity of artemisinin analogues.
    Guha R; Jurs PC
    J Chem Inf Comput Sci; 2004; 44(4):1440-9. PubMed ID: 15272852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Robust cross-validation of linear regression QSAR models.
    Konovalov DA; Llewellyn LE; Vander Heyden Y; Coomans D
    J Chem Inf Model; 2008 Oct; 48(10):2081-94. PubMed ID: 18826208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new hybrid system of QSAR models for predicting bioconcentration factors (BCF).
    Zhao C; Boriani E; Chana A; Roncaglioni A; Benfenati E
    Chemosphere; 2008 Dec; 73(11):1701-7. PubMed ID: 18954891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Critical assessment of QSAR models of environmental toxicity against Tetrahymena pyriformis: focusing on applicability domain and overfitting by variable selection.
    Tetko IV; Sushko I; Pandey AK; Zhu H; Tropsha A; Papa E; Oberg T; Todeschini R; Fourches D; Varnek A
    J Chem Inf Model; 2008 Sep; 48(9):1733-46. PubMed ID: 18729318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of linear, ensemble, and nonlinear models for the prediction and interpretation of the biological activity of a set of PDGFR inhibitors.
    Guha R; Jurs PC
    J Chem Inf Comput Sci; 2004; 44(6):2179-89. PubMed ID: 15554688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fuzzy tricentric pharmacophore fingerprints. 2. Application of topological fuzzy pharmacophore triplets in quantitative structure-activity relationships.
    Bonachéra F; Horvath D
    J Chem Inf Model; 2008 Feb; 48(2):409-25. PubMed ID: 18254617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. QSAR study of malonyl-CoA decarboxylase inhibitors using GA-MLR and a new strategy of consensus modeling.
    Li J; Lei B; Liu H; Li S; Yao X; Liu M; Gramatica P
    J Comput Chem; 2008 Dec; 29(16):2636-47. PubMed ID: 18484640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticancer activity of selected phenolic compounds: QSAR studies using ridge regression and neural networks.
    Nandi S; Vracko M; Bagchi MC
    Chem Biol Drug Des; 2007 Nov; 70(5):424-36. PubMed ID: 17949360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Models of steroid binding based on the minimum deviation of structurally assigned 13C NMR spectra analysis (MiDSASA).
    Beger RD; Harris S; Xie Q
    J Chem Inf Comput Sci; 2004; 44(4):1489-96. PubMed ID: 15272857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interpreting computational neural network QSAR models: a measure of descriptor importance.
    Guha R; Jurs PC
    J Chem Inf Model; 2005; 45(3):800-6. PubMed ID: 15921469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treating chemical diversity in QSAR analysis: modeling diverse HIV-1 integrase inhibitors using 4D fingerprints.
    Iyer M; Hopfinger AJ
    J Chem Inf Model; 2007; 47(5):1945-60. PubMed ID: 17661457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local and global quantitative structure-activity relationship modeling and prediction for the baseline toxicity.
    Yuan H; Wang Y; Cheng Y
    J Chem Inf Model; 2007; 47(1):159-69. PubMed ID: 17238261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Piecewise hypersphere modeling by particle swarm optimization in QSAR studies of bioactivities of chemical compounds.
    Lin WQ; Jiang JH; Shen Q; Wu HL; Shen GL; Yu RQ
    J Chem Inf Model; 2005; 45(3):535-41. PubMed ID: 15921443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Boosting: an ensemble learning tool for compound classification and QSAR modeling.
    Svetnik V; Wang T; Tong C; Liaw A; Sheridan RP; Song Q
    J Chem Inf Model; 2005; 45(3):786-99. PubMed ID: 15921468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. QSAR model for predicting pesticide aquatic toxicity.
    Mazzatorta P; Smiesko M; Lo Piparo E; Benfenati E
    J Chem Inf Model; 2005; 45(6):1767-74. PubMed ID: 16309283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
    Prado-Prado FJ; Martinez de la Vega O; Uriarte E; Ubeira FM; Chou KC; González-Díaz H
    Bioorg Med Chem; 2009 Jan; 17(2):569-75. PubMed ID: 19112024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimized partition of minimum spanning tree for piecewise modeling by particle swarm algorithm. QSAR studies of antagonism of angiotensin II antagonists.
    Shen Q; Jiang JH; Jiao CX; Huan SY; Shen GL; Yu RQ
    J Chem Inf Comput Sci; 2004; 44(6):2027-31. PubMed ID: 15554671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CARSVM: a class association rule-based classification framework and its application to gene expression data.
    Kianmehr K; Alhajj R
    Artif Intell Med; 2008 Sep; 44(1):7-25. PubMed ID: 18586476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploration of linear modelling techniques and their combination with multivariate adaptive regression splines to predict gastro-intestinal absorption of drugs.
    Deconinck E; Coomans D; Vander Heyden Y
    J Pharm Biomed Anal; 2007 Jan; 43(1):119-30. PubMed ID: 16859855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.